Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04964154
Other study ID # 1201571
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 17, 2021
Est. completion date June 30, 2022

Study information

Verified date July 2021
Source North Carolina Central University
Contact Deepak Kumar, PhD
Phone 919-530-7017
Email dkumar@ad.nccu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.


Recruitment information / eligibility

Status Recruiting
Enrollment 4000
Est. completion date June 30, 2022
Est. primary completion date March 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Self reports as Native American or American Indian Exclusion Criteria: - Does not self-report as Native American or American Indian

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Protect Your Elders Campaign
This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.

Locations

Country Name City State
United States Lumbee Tribe Tribal Housing Complex Pembroke North Carolina

Sponsors (3)

Lead Sponsor Collaborator
North Carolina Central University Lumbee Tribe of North Carolina, University of North Carolina at Pembroke

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increase in COVID-19 testing Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get tested for COVID-19. 1 month
Primary Increase in COVID-19 vaccination Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get vaccinated against COVID-19. 1 month
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05087225 - Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia
Recruiting NCT04790240 - Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) Phase 1/Phase 2